Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 1,292 | 3,825 | 2,369 | 0 | 166 |
Gross Profit | 1,292 | 3,825 | 2,369 | N/A | 166 |
Operating Expenses | 40,440 | 15,474 | 45,863 | 46,481 | 41,950 |
Operating Income | -39,148 | -11,649 | -43,494 | -46,481 | -41,784 |
Interest Expense | 4,905 | 3,455 | 1,850 | 1,810 | 1,790 |
Other Income | 4,228 | 7,675 | -3,575 | -1,242 | 888 |
Pre-tax Income | -39,825 | -7,429 | -48,919 | -49,533 | -42,686 |
Income Tax | -14 | 19,522 | -6,152 | -7,474 | -5,624 |
Net Income Continuous | -39,811 | -26,951 | -42,767 | -42,059 | -37,062 |
Net Income | $-39,811 | $-26,951 | $-42,767 | $-42,059 | $-37,062 |
EPS Basic Total Ops | -0.23 | -0.23 | -0.47 | -0.46 | -0.41 |
EPS Basic Continuous Ops | -0.23 | -0.23 | -0.47 | -0.46 | -0.41 |
EPS Diluted Total Ops | -0.23 | -0.23 | -0.47 | -0.46 | -0.41 |
EPS Diluted Continuous Ops | -0.23 | -0.23 | -0.47 | -0.46 | -0.41 |
EPS Diluted Before Non-Recurring Items | -0.23 | -0.23 | -0.47 | N/A | N/A |
EBITDA(a) | $-37,249 | $-10,000 | $-41,707 | $-44,562 | $-39,717 |